Difference between revisions of "Aspirin and dipyridamole (Aggrenox)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
m |
||
| (One intermediate revision by the same user not shown) | |||
| Line 5: | Line 5: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| + | [[Category:Combination drugs]] | ||
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
| Line 12: | Line 13: | ||
[[Category:FDA approved in 1999]] | [[Category:FDA approved in 1999]] | ||
| − | |||
Latest revision as of 22:08, 22 March 2022
From the FDA label: A combination antiplatelet agent. Each hard gelatin capsule contains 200 mg of dipyridamole in an extended-release form and 25 mg of aspirin, as an immediate-release sugar-coated tablet.
Also known as
- Brand name: Aggrenox